pharmaphorum

NOVEMBER 9, 2021

Yet how many other therapy areas have market leaders that don’t even have clinical approved indication in that indication? Michael’s areas of expertise span the clinical and commercial aspects of oncology markets. She has a good understanding of marketing strategy. The success of branding in immuno-oncology.

Cerner 98

Cerner 98

Pharmaceutical Technology

DECEMBER 12, 2022

The development, clinical trial and marketing expenses for the cell therapy will be shared by the companies while co-commercialising the product and equally splitting profits from the US region. Kite will oversee the marketing of the product outside the US while Arcellx is eligible for royalty payments on sales.

Communication 105

Communication 105

Integra X Files

MARCH 6, 2023

The challenge is to find the time and resources to manage a marketing program while continuing to fully serve existing clients. Allocating a marketing budget will help. A Look at Your Pharmacy’s Market Have you taken time for a deep look at your competitors and potential new customers? to 5% of total revenue on marketing.

Assisted Living 81

Assisted Living Nursing Homes 81

Pharmaceutical Technology

DECEMBER 14, 2022

Additionally, for WVE-006, GSK will make development and launch milestone payments of up to $225m to Wave, which is also eligible to get up to $300m in milestone payments based on sales. On completion of the first-in-patient clinical trial by Wave, GSK will be in charge of the development and marketing works.

Communication 64

Communication 64

Pharma Marketing Network

JULY 21, 2023

Some examples of content you could share include: news articles about new drugs or treatments, blog posts about your work in the pharmaceutical industry, or white papers on industry-related topics. Sales Navigator offers a variety of features that can help you target your outreach and track your results.

Drug Development 52

Drug Development 52

pharmaphorum

NOVEMBER 20, 2020

Gordon joins Prescient with more than 15 years of dedicated oncology experience in market research and competitive intelligence. He has an MBA in market and strategy from Carnegie Mellon University and a BA in biochemistry from the University of Pennsylvania.

Medical Schools 65

Medical Schools 65

Pharmaceutical Technology

FEBRUARY 17, 2023

Additionally, Capricor will receive up to $89m in further development and sales-based milestones, along with a double-digit share of revenue based on product sales. According to the deal, Capricor will receive $12m in upfront payment from Nippon Shinyaku.

Labelling 52

Labelling Communication 52

Pharmaceutical Technology

JANUARY 10, 2023

It is also eligible for $268m in discovery, regulatory, preclinical, clinical, and commercial milestones and royalties on future sales of Boehringer Ingelheim products. Furthermore, Boehringer Ingelheim will receive royalties on product sales in the future by 3T Biosciences.

Immunity 52

Immunity Immunization Compounding Communication 52

Pharmaceutical Technology

JANUARY 11, 2023

AbbVie will get exclusive rights to license and develop and market the programmes. The company will also receive further commercial milestones and tiered royalty payments on net sales of the products. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Communication 59

Communication 59

Pharmaceutical Technology

FEBRUARY 23, 2023

The company will also receive tiered royalties on the worldwide net sales of products developed from the collaboration. Moderna will also assume further development, manufacturing, and commercialisation responsibilities on exercising a target option. Life Edit will get an upfront payment and is eligible for potential milestone payments.

Communication 59

Communication 59

Pharmaceutical Technology

JANUARY 20, 2023

billion in Covid-19 vaccine sales. In a January business update , the company predicted it will make a minimum of $5 billion in new vaccine sales. In 2021, Moderna had a net income of $12.2 In 2022, it was reported that Moderna made $18.4 This is particularly important as the new variant XBB.1.5

Vaccines 98

Vaccines Communication 98

pharmaphorum

DECEMBER 12, 2022

The demand for high-calibre, sharply-focussed clinical knowledge and data is increasing as HCPs streamline and recalibrate their engagements with the pharmaceutical sector.

Communication 103

Communication 103

pharmaphorum

JULY 5, 2022

Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. With more than 500 dermatology clinical trials currently underway, it is often heard that there is a ‘’competition for participants’’.

Communication 115

Communication 115

PharmaKinnex

APRIL 13, 2022

Pharma Marketing Solutions That Help Address Whitespace April 13, 2022. Whitespace in pharma marketing refers are areas where pharma companies don’t add a field salesforce presence in because of the lack of ROI caused by smaller population size and lower sales potential for each physician. Direct & Digital Storytelling .

Medical Records 52

Medical Records Pharmaceutical Companies Pharmaceutical Companies Hospitals 52

pharmaphorum

MARCH 4, 2022

It is clear that sales forces and MSL teams need to enhance their skills to make every second of their precious time in front of HCPs count. The pharmaceutical industry is still picking its way through the debris of the pandemic but the gloom can be illuminated by the power of coaching to drive connections and value.

Communication 98

Communication 98

pharmaphorum

OCTOBER 5, 2021

Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisation in the healthcare industry. As part of these efforts, customer experience (CX) became a key focus area to ensure customer engagement and loyalty.

Pharmaceutical Companies 116

Pharmaceutical Companies Pharmaceutical Companies 116

pharmaphorum

APRIL 19, 2022

Marketing Permissions . By clicking on subscribe you consent to pharmaphorum media and Within3 occasionally sending you marketing emails in compliance with GDPR rules. We use Mailchimp as our marketing platform. Whitepaper download. indicates required. Email Address *. First Name *. Last Name *. Job title *. Organisation *.

98

98

pharmaphorum

NOVEMBER 3, 2021

Using content metrics, companies can understand how their current content is received and engaged with, which will, in turn, helps clarify the most effective and efficient ways to connect and communicate with their audience in the future, resulting in increased speed to market and effective content engagement.

Compounding 98

Compounding Communication Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

MARCH 15, 2022

Marketing Permissions. By clicking on subscribe you consent to pharmaphorum media and Within3 occasionally sending you marketing emails in compliance with GDPR rules. We use Mailchimp as our marketing platform. Whitepaper download. indicates required. Email Address *. First Name *. Last Name *. Job title *. Organisation *.

98

98

pharmaphorum

MAY 13, 2021

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. Make it easy for the sales team. Require data-driven decision making. Build a data infrastructure.

Communication 103

Communication Pharmaceutical Companies Pharmaceutical Companies 103

pharmaphorum

JANUARY 19, 2021

In a remote world, customer data is more foundational than ever, and Veeva’s 2020 European Customer Reference Data Survey found 91% of organisations view customer data as a global strategic asset, while 88% said it’s essential for new product launches or sales models. The impact of good data on product launches and sales models.

98

98

pharmaphorum

NOVEMBER 4, 2022

The value of data has never been greater in healthcare. With greater digital engagement and opportunities available as the world emerges from the COVID-19 pandemic, putting data to use is critical for healthcare and the pharmaceutical industry.

Communication 57

Communication 57

Pharmaceutical Technology

JANUARY 31, 2023

Under the terms of the deal, uniQure will obtain the worldwide rights to develop and market the clinical stage gene therapy, APB-102. uniQure will also provide tiered royalties ranging from mid-single digits to low double digits on the net sales. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.

Communication 111

Communication 111

pharmaphorum

JUNE 29, 2022

The prescription medicine market has recovered from the wild swings of the early pandemic with renewed growth. COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026.

HIV Treatment and Prevention Agents 57

HIV Treatment and Prevention Agents Vaccines Pharmaceutical Companies Pharmaceutical Companies 57

pharmaphorum

JUNE 1, 2022

To improve outcomes for cancer patients and take advantage of the ground-breaking scientific and technological progress made in oncology prevention, diagnosis, therapy and care over recent years, it is of crucial importance to ensure all patients with cancer have an ongoing dialogue with the healthcare team.

Pharmaceutical Companies 57

Pharmaceutical Companies Pharmaceutical Companies 57

pharmaphorum

JANUARY 21, 2021

At a time when pharma marketing materials are often recreated and reapproved multiple times, and when regional teams can struggle to reuse assets across different regions, a dramatic shift in how to draft, review and distribute assets is needed. The key questions sales and marketing executives should ask of their content.

67

67

Pharma Marketing Network

JUNE 8, 2020

RJ (PMN): Hi this is RJ Lewis, your host of the pharma marketing network podcast and I’m excited today to have with me a couple of executives from Klick Health to talk about CCPA. Since Apple went down the path of blocking third party cookies, a lot of marketing and ad tech is actually based off of that infrastructure.

HIPAA 40

HIPAA Pharmaceutical Companies Pharmaceutical Companies Communication 40

pharmaphorum

JANUARY 14, 2021

The promotional environments of major pharmaceutical markets were already divergent in 2019 – some, like Italy and Spain were very high on traditional face to face interactions, others, like the UK, were the complete opposite, and still others, like Japan and the US, had high volumes of both digital and face to face contacts.

Biosimilars 68

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Labelling 68

Pharmaceutical Technology

FEBRUARY 24, 2023

It will also get mid-to-high single-digit royalty payments on future product sales. Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Communication 52

Communication Drug Development 52

Pharma Marketing Network

JULY 21, 2023

The pharmaceutical industry is a highly regulated one, and as such, traditional marketing channels such as advertising can be limited. However, content marketing is a great way for pharmaceutical companies to reach their target audience and drive sales.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

JULY 29, 2022

As a marketing tool, email allows delivering well-targeted messages to the recipients, highlighting the key point of your emails and it is a fast and simple way to communicate with your target audience. As well, many marketing practices and tools frequently turn out to be task-irrelevant or simply obsolete.

Communication 52

Communication 52

pharmaphorum

OCTOBER 20, 2020

IQVIA’s full year ChannelDynamics review covering promotional activity to the end of 2019 shows that face-to-face selling remained the globally preferred channel, with just over 60% of measured marketing expenditure placed on reps – a level that has remained constant for several years. The post Time to change the channel?

Pharmaceutical Companies 120

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 120

pharmaphorum

SEPTEMBER 2, 2022

MSLs are in prime position to build new structures of engagement as the pharma industry recalibrates after the disruptive force of the pandemic. COVID-enforced changes are not going to simply bounce back into shape so organisations need new ways of connecting with HCPs and delivering scientific knowledge directly to their needs: step forward MSLs.

Communication 98

Communication 98

pharmaphorum

OCTOBER 27, 2020

Now our submissions are higher quality, workflow isn’t held up, and the review process is quicker, ” said the company’s director of marketing services, adding: “ I can’t imagine using two systems for MLR review and DAM—one solution for both is incomparable. ”. Our goal was to have a single solution for both MLR review and DAM.

Pharmaceutical Companies 62

Pharmaceutical Companies Pharmaceutical Companies 62

Pharmaceutical Technology

DECEMBER 9, 2022

Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. Pharmaceutical sales in Brazil reached $17bn in 2021, according to GlobalData figures. The generics market in Brazil. by 2040 based on statistics from OECD.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

MARCH 6, 2023

Teijin Pharma is also eligible for up to $200m in potential development and commercial milestone payments along with further additional sales milestones as well as tiered annual net sales royalties. According to the agreements, Novartis will make $30m in an upfront cash payment to Teijin Pharma.

Compounding 105

Compounding Communication Drug Development 105

Pharmaceutical Technology

JANUARY 6, 2023

The agreement outlined that Par would keep its generic equivalent off the market for as many as two years, delaying the generic launch till September 30, 2014. In a press release, the company said a generic launch would damage sales in FY 2023 by $300,000. These actions allegedly led to the extension of Novartis’ patents.

Documentation 97

Documentation Hospitals Dosage Drug Pricing 97